Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Managementarticle Published on 2023-04-152024-09-02 Journal: Cornea [Category] 대상포진, [키워드] belantamab mafodotin Dupilumab ocular surface disease tralokinumab [DOI] 10.1097/ICO.0000000000003162 PMC 바로가기 [Article Type] article
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment골수종 환자의 Covid-19 백신 접종 후 중화 항체 반응은 항-미 일종 치료의 유형에 크게 의존합니다.Multicenter Study Published on 2021-08-022022-09-01 Journal: Blood Cancer Journal [Category] MERS, SARS, 임상, 진단, 치료법, [키워드] active treatment anti-CD38 antibodies antibody Antibody Response AZD1222 belantamab mafodotin BNT162b2 Cell Comparisons Control COVID-19 vaccination dependent on dose enrolled evaluated healthy control Hematological malignancies humoral independent infection control leads lymphopenia mAbs MAFODOTIN measure monoclonal antibody Myeloma NAb nAb response NAbs neoplasm Neutralizing antibodies Neutralizing antibody response non-responders Patient plasma Plasma cell Prognostic factor recent responders SARS-CoV-2 SARS-CoV-2 vaccination Treatment vaccination Vaccine [DOI] 10.1038/s41408-021-00530-3 PMC 바로가기 [Article Type] Multicenter Study